Product Images Levetiracetam

Levetiracetam Tablets, USP is a medicine that contains 500 mg of Levetiracetam, USP. Each patient taking this medicine is required to receive the accompanying Medication Guide. The recommended storage temperature for this medicine is between 20" to 25°C (68" to 77°F) with excursions permitted between 15" to 30°C. It should be dispensed by a pharmacist in a tight, light-resistant container with a child-resistant closure. The detailed dosage recommendation is provided in the package insert. This medicine is manufactured by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, and distributed by Rev. 11-2017-01.*

This is a medication description for Levetiracetam Tablets, USP containing 750mg of Levetiracetam. It includes the NDC code and recommended dosage as well as storage instructions. Pharmacists are instructed to dispense the tablets in a light-resistant container and provide the accompanying Medication Guide. The medication is distributed by Amneal Pharmaceuticals LLC.*

This is a description of a medication called Levetiracetam, which comes in tablet form with a strength of 1000mg. The typical dosage is described in the package insert. It should be stored at a specific temperature range and dispensed in a light-resistant container with child-resistant closure. Additionally, it is required that each patient receives a Medication Guide from the pharmacist. The medication is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*

This text represents the results of a clinical trial study comparing the effectiveness of placebo and levetiracetam 3000 mg/day in treating a certain medical condition. The results indicate that 39.4% of the patients who received placebo reported improvement, while 40% of those who received levetiracetam reported improvement. 35% of the patients had an unknown status. Additionally, 14.4% of patients experienced side effects. A total of 104 participants were in the placebo group and 180 in the levetiracetam group.*

This text appears to be a table or chart showing percentages and patient numbers for two groups of patients receiving different treatments, placebo and levetiracetam. The numbers may represent the percentage of patients who experienced a certain outcome, but no information is given about what that outcome is. Without additional context or information, it is not possible to provide a more specific description or interpretation.*

This text provides information on the percentage of patients who received a placebo (N=51) or Levetiracetam (N=58). The table indicates that Levetiracetam had a statistically significant effect compared to the placebo, but there is no additional context provided.*

This is a medication used for treating epilepsy and seizures called Levetiracetam. It comes in the form of tablets containing 120 tablets with an NDC code of 65162-528-16. The medication guide that comes with this medicine needs to be provided to each patient. The storage requirements of this medicine are within 20 to 25C with excursions allowed between 15 to 30C. The medication needs to be dispensed in a light-resistant container with a child-proof closure. It is distributed by Amneal Pharmaceuticals LLC, and the recommended dosage can be found in the package insert.*